Chemical Compound

Repaglinide

CAS Registry Number 135062-02-1
Back to search Request a Quote
Repaglinide chemical structure
Primary Record

Repaglinide

In stock
8,253 g
Purity
98.9 %
CAS
135062-02-1

Compound Identifiers & Properties

CAS
135062-02-1
PubChem CID
65981
SMILES
CCOC1=C(C=CC(=C1)CC(=O)N[C@@H](CC(C)C)C2=CC=CC=C2N3CCCCC3)C(=O)O
Canonical SMILES
CCOc1cc(CC(=O)N[C@@H](CC(C)C)c2ccccc2N2CCCCC2)ccc1C(=O)O

Names & Synonyms

  • Repaglinide
  • Prandin
  • NovoNorm
  • 135062-02-1
  • GlucoNorm
  • Repaglinida
  • Repaglinidum
  • enyglid
  • Surepost
  • Actulin
  • Reglin
  • repa-glinide
  • Repaglinide [USAN]
  • AG-EE 623 ZW
  • Novonorm;
  • Repaglinidum [INN-Latin]
  • Novonorm/Prandin
  • Repaglinide CRS
  • Repaglinida [INN-Spanish]
  • Prandin (TN)
  • (S)-Repaglinide
  • AGEE-623ZW
  • (+)-repaglinide
  • AG-EE 388 ZW
  • (-)-Repaglinide
  • GlucoNorm (TN)
  • Surepost (TN)
  • NovoNorm (TN)
  • Repaglinide-ethyl-d5
  • repaglinide impurity E
  • AG-EE-623ZW
  • Repaglinide (Standard)
  • RefChem:56406
  • AG-EE 623ZW
  • C27H36N2O4
  • (S)-(+)-Repaglinide
  • AC1Q5TZW
  • REPAGLINIDE [MI]
  • Prestwick0_001046
  • Prestwick1_001046
  • Prestwick2_001046
  • Prestwick3_001046
  • AG-EE-623-ZW
  • CHEMBL1272
  • REPAGLINIDE [INN]
  • REPAGLINIDE [JAN]
  • DTXSID3023552
  • MFCD00906179
  • Prandin;GlucoNorm;NovoNorm
  • D0N5YA
  • Repaglinide (JAN/USP/INN)
  • AG-EE 388
  • REPAGLINIDE [VANDF]
  • repaglinide, (+-)-isomer
  • UNII-668Z8C33LU
  • A10BX02
  • AG-EE-623 ZW
  • DTXCID603552
  • 668Z8C33LU
  • REPAGLINIDE [MART.]
  • SCHEMBL16137
  • BSPBio_000972
  • REPAGLINIDE [USP-RS]
  • REPAGLINIDE [WHO-DD]
  • AG-EE-388
  • MLS000759407
  • MLS001076684
  • MLS001424111
  • MLS006011560
  • AG-EE-388ZW
  • BIDD:GT0338
  • NSC-759893
  • SMP-508
  • SPBio_002906
  • FAEKWTJYAYMJKF-QHCPKHFHSA-N
  • REPAGLINIDE [EMA EPAR]
  • AC1L24D5
  • BPBio1_001070
  • CHEBI:8805
  • GTPL6841
  • orb1309813
  • (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
  • Repaglinide, 98% - 1g 1g
  • Repaglinide - Bio-X trade mark
  • Repaglinide [USAN:USP:INN:BAN]
  • SCHEMBL29373506
  • SCHEMBL29392295
  • AG-EE-623
  • CTK3J7345
  • MSK7195
  • Novo Nordisk brand of repaglinide
  • REPAGLINIDE [ORANGE BOOK]
  • NN-623
  • Repaglinide for system suitability
  • GLXC-05202
  • HMS1571A14
  • HMS2051N08
  • HMS2094C07
  • HMS2098A14
  • HMS2231M21
  • HMS3414D09
  • HMS3678D09
  • HMS3715A14
  • Pharmakon1600-01506035
  • REPAGLINIDE [EP MONOGRAPH]
  • Glaxo Wellcome brand of replaginide
  • REPAGLINIDE [USP MONOGRAPH]
  • BCP04250
  • CID65981
  • KS-00000GU9
  • ZINC3798537
  • Novo Nordisk brand 2 of repaglinide
  • Tox21_110721
  • AC-726
  • ANW-63956
  • BDBM50153520
  • EBC-06064
  • HB1106
  • HY-15209R
  • MSK7195-100A
  • NCGC00016978-01
  • NP3248
  • NSC759893
  • s1426
  • STK629501
  • 111GE012
  • AKOS005561792
  • C27-H36-N2-O4
  • MSK7195-1000A
  • Repaglinide for system suitability CRS
  • Repaglinide, >=98% (HPLC), solid
  • ACN-034460
  • BS-1010
  • CCG-101013
  • CS-0979
  • DB00912
  • FR27699
  • NC00263
  • NSC 759893
  • RTC-063882
  • CAS-135062-02-1
  • NCGC00016978-02
  • NCGC00016978-04
  • NCGC00016978-05
  • NCGC00016978-15
  • AJ-45642
  • AN-15576
  • BC220160
  • BR164332
  • CPD000466305
  • HY-15209
  • I979
  • LS-38509
  • SAM001246546
  • SC-17344
  • SMR000466305
  • SY046828
  • Prandin, GlucoNorm, NovoNorm, Repaglinide
  • SBI-0206942.P001
  • AB0013959
  • AB2000099
  • J555.407A
  • TC-063882
  • 2-ethoxy-4-[2-[[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino]-2-oxoethyl]benzoic acid
  • AB00514019
  • AM20090697
  • FT-0631150
  • FT-0674344
  • FT-0674345
  • R0179
  • ST24036034
  • SW197344-4
  • (R)-(-)-Repaglinide (Repaglinide Impurity)
  • 62R021
  • A10783
  • C07670
  • D00594
  • F15001
  • Repaglinide Solution in Acetonitrile, 100ug/mL
  • W-5210
  • AB00514019-09
  • AB00514019_10
  • AB00514019_11
  • Repaglinide Solution in Acetonitrile, 1000ug/mL
  • (S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid
  • 2-ethoxy-4-({[(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl]carbamoyl}methyl)benzoic acid
  • 2-Ethoxy-4-[2-[[(1S)-3-Methyl-1-[2-(1-Piperidinyl)Phenyl]Butyl]Amino]-2-Oxoethyl]Benzoic Acid
  • A806877
  • SR-01000759404
  • Q2195995
  • SR-01000759404-4
  • (+)-2-Ethoxy-alpha-(((S)-alpha-isobutyl-o-piperidinobenzyl)carbamoyl)-p-toluic acid
  • (S)-(+)-2-Ethoxy-4-[N-[1-(2-piperidinophenyl)-3-methyl-1-butyl]aminocarbonylmethyl]benzoic acid
  • (S)-2-ethoxy-4-(2-(3-methyl-1-(2-(piperidin-1-yl)phenyl)butylamino)-2-oxoethyl)benzoic acid
  • 2-ethoxy-4-[2-({(1S)-3-methyl-1-[2-(piperidin-1-yl)phenyl]butyl}amino)-2-oxoethyl]benzoic acid
  • BRD-K82846253-001-03-0
  • BRD-K82846253-001-14-7
  • BRD-K82846253-001-15-4
  • BRD-K82846253-001-16-2
  • Z1501485370
  • (S)-2-Ethoxy-4-(2-((methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-benzoic acid
  • 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
  • 2-ethoxy-N-(alpha-(2-methyl-1-propyl)-2-piperidinobenzyl)-4-carbamoylmethylbenzoic acid
  • Repaglinide, European Pharmacopoeia (EP) Reference Standard
  • (S)-2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)-phenyl)butyl)amino)-2-oxoethyl)-benzoic acid
  • Benzoic acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-, (S)-
  • (S)-2-Ethoxy-4-[2-[[3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid
  • Repaglinide, United States Pharmacopeia (USP) Reference Standard
  • (S)-2-Ethoxy-4-[2-[[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic Acid
  • 2-ethoxy-4-(2-{[(1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl]amino}-2-oxoethyl)benzoic acid
  • 2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidyl)phenyl]butyl]amino]-2-oxo-ethyl]benzoic acid
  • (+)-2-ethoxy-alpha-[[(s)-alpha-isobutyl-o-piperidinobenzyl]carbamoyl]-p-toluic acid
  • (s)-(+)-2-ethoxy-4-(2-oxo-2-[(alpha-isobutyl-2-piperidinobenzyl)amino]ethyl)-benzoic acid
  • 2-Ethoxy-4-[2-[[(S)-alpha-isobutyl-2-piperidinobenzyl]amino]-2-oxoethyl]benzoic acid
  • 2-Ethoxy-4-[2-oxo-2-[[(S)-alpha-isobutyl-2-piperidinobenzyl]amino]ethyl]benzoic acid
  • Repaglinide for system suitability, European Pharmacopoeia (EP) Reference Standard
  • (+)-2-ETHOXY-.ALPHA.-(((S)-.ALPHA.-ISOBUTYL-O-PIPERIDINOBENZYL)CARBAMOYL)-P-TOLUIC ACID
  • (S)-2-Ethoxy-4-(2-((3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)amino)-2-oxoethyl)benzoicacid
  • (S)-2-ETHOXY-4-(2-(METHYL-1-(2-(1-PIPERIDINYL)PHENYL)BUTYLAMINO)-2-OXOETHYL)-BENZOIC ACID
  • (S)-2-Ethoxy-4-[N-(1-(2-piperidino-phenyl)-3-methyl-1-butyl)-aminocarbonylmethyl]-benzoic acid
  • 1217709-85-7
  • 147852-26-4
  • 2-ethoxy-4-((((1S)-3-methyl-1-(2-(piperidin-1-yl)phenyl)butyl)carbamoyl)methyl)benzoic acid
  • 2-ethoxy-4-(2-(((1R)-3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)benzoic acid
  • 2-ethoxy-4-(2-(((1S)-3-methyl-1-(2-piperidin-1-ylphenyl)butyl)amino)-2-oxoethyl)benzoic acid
  • 2-Ethoxy-4-[2-[[(S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]benzoic acid
  • 2-Ethoxy-4-{[(S)-3-methyl-1-(2-piperidin-1-yl-phenyl)-butylcarbamoyl]-methyl}-benzoic acid
  • 629-921-1
  • Benzoic Acid, 2-ethoxy-4-(2-((3-methyl-1-(2-(1-piperidinyl)phenyl)butyl)amino)-2-oxoethyl)-,(S)-
  • Benzoic acid,2-ethoxy-4-[2-[[(1S)-3-methyl-1-[2-(1-piperidinyl)phenyl]butyl]amino]-2-oxoethyl]-
  • BJX